Premier Anti-Aging Co., Ltd. (JP:4934)
:4934
Want to see JP:4934 full AI Analyst Report?
4934 Stock Chart & Stats
¥702.00
-¥12.00(-1.43%)
At close: 4:00 PM EST
¥702.00
-¥12.00(-1.43%)
Day’s Range― - ―
52-Week Range¥576.00 - ¥950.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)11.01K
Market Cap
¥5.14B
Enterprise Value¥1.61B
Total Cash (Recent Filing)¥4.66B
Total Debt (Recent Filing)¥1.11B
Price to Earnings (P/E)20.5
Beta0.94
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)54.02
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)37.8
Revenue Forecast (FY)¥14.40B
Bulls Say, Bears Say
Bulls Say
Gross Profit MarginA 76.65% gross margin indicates enduring product or pricing advantages and efficient cost of goods sold. This margin cushion helps absorb revenue volatility, funds marketing/R&D reinvestment, and supports long-term cash generation even if top-line growth is slow.
Conservative LeverageA low debt-to-equity ratio (0.17) and healthy equity base provide financial resilience, lower interest burden, and greater flexibility to invest or weather downturns. This conservative capital structure supports sustained operations and strategic moves without heavy refinancing risk.
Strong FCF ConversionHigh free cash flow conversion (FCF/net income ~0.98) shows the company converts accounting profits into real cash, enabling self-funding for capex, product development, or debt reduction. Durable cash conversion supports long-term financial flexibility.
Bears Say
Declining RevenueAn ~18% decline in revenue is a structural headwind that erodes scale, reduces pricing leverage, and can make fixed costs harder to cover. Persistent top-line contraction undermines long-term margin recovery and constrains ability to fund growth initiatives from internal cash.
Low Net Profit MarginA slim net margin (~2.9%) despite a high gross margin suggests operating expenses or SG&A consumption that limit profitability. This weak bottom-line conversion reduces retained earnings, limits reinvestment, and makes returns sensitive to cost inflation or revenue dips.
Moderate Cash QualityAn OCF-to-net-income ratio of ~0.49 signals that reported earnings are not fully matched by operating cash, implying earnings quality or timing issues. Over time this can restrict sustainable reinvestment, dividend potential, and the buffer against cyclical revenue weakness.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥576.00 and its highest was ¥950.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.14B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Sep 10, 2026 which is in 81 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Jun 12, 2026. The company reported ¥11.14 earnings per share for the quarter, beating the consensus estimate of N/A by ¥11.14.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥11.14 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.332%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. is a multifaceted company engaged in the entire lifecycle of cosmetics and health food products, from their initial planning and development to import/export, wholesale, and retail, including mail order. The company markets its cosmetic lines primarily under the DUO and CANADEL brands. Additionally, it offers consulting and informational services centered on anti-aging, beauty, and general wellness. Its activities also encompass research into the operational and aesthetic aspects of beauty clinics, along with broader market intelligence gathering and data analysis. Established in 2009, the firm is headquartered in Tokyo, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―